GGrantIndex
← Leaderboards

Heinrich Feldmann

National Institute Of Allergy And Infectious Diseases

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Most similar at National Institute Of Allergy And Infectious Diseases

Same institution · by research overlap

Others in their field

Top investigators on “Virus

Research focus

VirusVaccinesAnimalsAnimal ModelPathogenViralInfectionVirus DiseasesResponseNational Institute Of Allergy And Infectious DiseaseIn VitroBaseVectorFilovirusRodentVesicular Stomatitis Indiana VirusPathogenicityNonhuman PrimateImmune ResponseInternationalTransmission ProcessVaccinationLaboratoriesVaccine Candidate

Grant awards (71)

Viral Hemorrhagic Fevers: Disease Modeling and Transmission$3,668,794
ZIA · FY2025 · AI · contact PI
Universal Influenza Vaccines (UIV)$725,497
ZIA · FY2025 · AI · contact PI
Mali International Center for Excellence in Research$409,090
ZIA · FY2025 · AI · contact PI
Uganda International Center for Excellence in Research$148,462
ZIA · FY2025 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$6,531,361
ZIA · FY2024 · AI · contact PI
Uganda International Center for Excellence in Research$182,814
ZIA · FY2024 · AI · contact PI
Mali International Center for Excellence in Research$40,505
ZIA · FY2024 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$2,115,203
ZIA · FY2023 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$2,115,203
ZIA · FY2023 · AI · contact PI
Uganda International Center for Excellence in Research$723,766
ZIA · FY2023 · AI · contact PI
SARS-CoV-2: Pathogenesis and Countermeasure Development$341,507
ZIA · FY2023 · AI · contact PI
Mali International Center for Excellence in Research$66,330
ZIA · FY2023 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$5,627,958
ZIA · FY2022 · AI · contact PI
Mali International Center for Excellence in Research$600,116
ZIA · FY2022 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$456,404
ZIA · FY2022 · AI · contact PI
SARS-CoV-2: Pathogenesis and Countermeasure Development$208,265
ZIA · FY2022 · AI · contact PI
Uganda International Center for Excellence in Research$185,448
ZIA · FY2022 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$2,700,161
ZIA · FY2021 · AI · contact PI
Uganda International Center for Excellence in Research$618,078
ZIA · FY2021 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$476,501
ZIA · FY2021 · AI · contact PI
Mali International Center for Excellence in Research$312,306
ZIA · FY2021 · AI · contact PI
SARS-CoV-2: Pathogenesis and Countermeasure Development$203,488
ZIA · FY2021 · AI · contact PI
SARS-CoV-2: Pathogenesis and Countermeasure Development$2,585,920
ZIA · FY2020 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$1,998,462
ZIA · FY2020 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$856,485
ZIA · FY2020 · AI · contact PI
Mali International Center for Excellence in Research$578,156
ZIA · FY2020 · AI · contact PI
Uganda International Center for Excellence in Research$66,415
ZIA · FY2020 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$1,907,967
ZIA · FY2019 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$953,984
ZIA · FY2019 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$953,984
ZIA · FY2019 · AI · contact PI
Mali International Center for Excellence in Research$271,768
ZIA · FY2019 · AI · contact PI
Uganda International Center for Excellence in Research$63,546
ZIA · FY2019 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$2,268,135
ZIA · FY2018 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$648,038
ZIA · FY2018 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$324,019
ZIA · FY2018 · AI · contact PI
Mali International Center for Excellence in Research$133,436
ZIA · FY2018 · AI · contact PI
Uganda International Center for Excellence in Research$66,420
ZIA · FY2018 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$2,762,918
ZIA · FY2017 · AI · contact PI
Mali International Center for Excellence in Research$257,611
ZIA · FY2017 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$153,495
ZIA · FY2017 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$153,495
ZIA · FY2017 · AI · contact PI
Uganda International Center for Excellence in Research$66,675
ZIA · FY2017 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$3,493,059
ZIA · FY2016 · AI · contact PI
Mali International Center for Excellence in Research$325,343
ZIA · FY2016 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$121,667
ZIA · FY2016 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$121,667
ZIA · FY2016 · AI · contact PI
Uganda International Center for Excellence in Research$47,578
ZIA · FY2016 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$898,846
ZIA · FY2015 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$898,846
ZIA · FY2015 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$770,440
ZIA · FY2015 · AI · contact PI
Mali International Center for Excellence in Research$112,002
ZIA · FY2015 · AI · contact PI
Uganda International Center for Excellence in Research$38,809
ZIA · FY2015 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$2,054,761
ZIA · FY2014 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$1,005,748
ZIA · FY2014 · AI · contact PI
Mali International Center for Excellence in Research$407,551
ZIA · FY2014 · AI · contact PI
Understanding the Emergence of Highly Pathogenic Avian Influenza Viruses$251,437
ZIA · FY2014 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$251,437
ZIA · FY2014 · AI · contact PI
Uganda International Center for Excellence in Research$197,349
ZIA · FY2014 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$2,775,051
ZIA · FY2013 · AI · contact PI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens$1,082,258
ZIA · FY2013 · AI · contact PI
Understanding the Emergence of Highly Pathogenic Avian Influenza Viruses$811,693
ZIA · FY2013 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$811,693
ZIA · FY2013 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$1,985,455
ZIA · FY2012 · AI · contact PI
H1N1 Influenza Disease Modeling and Transmission$640,116
ZIA · FY2012 · AI · contact PI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination$543,939
ZIA · FY2012 · AI · contact PI
Understanding the Emergence of Highly Pathogenic Avian Influenza Viruses$254,694
ZIA · FY2012 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$3,347,398
ZIA · FY2011 · AI · contact PI
H1N1 Influenza Disease Modeling and Transmission$170,904
ZIA · FY2011 · AI · contact PI
ARRA: H1N1 Influenza Disease Modeling and Transmission$4,154,469
ZIA · FY2010 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$3,552,426
ZIA · FY2010 · AI · contact PI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission$3,012,906
ZIA · FY2009 · AI · contact PI